Company Filing History:
Years Active: 2024
Title: Innovations in Cancer Treatment by David Briere
Introduction
David Briere is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of cancer treatment, particularly through his innovative approaches to combination therapies. His work focuses on addressing KRas G12C cancers, which are known for their challenging treatment landscape.
Latest Patents
David Briere holds a patent related to combination therapies for treating KRas G12C cancers. This patent outlines methods for treating cancer in subjects by administering a therapeutically effective amount of a combination of an agent that blocks Programmed Death-1 receptor (PD-1) and Programmed Death Ligand-1 (PD-L1) signaling, along with a KRAS G12C inhibitor. The patent includes formulations and kits that comprise these compositions, showcasing his commitment to advancing cancer therapies.
Career Highlights
Briere is associated with Mirati Therapeutics, Inc., a company dedicated to developing innovative medicines for cancer treatment. His role at Mirati Therapeutics allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts.
Collaborations
David Briere has worked alongside notable colleagues, including James Gail Christensen and Peter Olson. These collaborations enhance the research environment and foster the exchange of ideas that can lead to further advancements in cancer therapies.
Conclusion
David Briere's work in developing combination therapies for KRas G12C cancers exemplifies the innovative spirit of modern medicine. His contributions are paving the way for more effective cancer treatments, ultimately benefiting patients in need.